Recent Updates
Recently added Catalysts
EBS Positive Sentiment

Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024

Monday, April 22, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Emergent BioSolutions Inc. has announced a conference call scheduled for May 1, 2024, to discuss its financial results for the first quarter of 2024. During the call, the company will also provide updates about its business and revenue guidance for the upcoming second quarter and the full year. Participants can join the call via a webcast or by telephone after registering. A replay will be available on the company's Investors page following the event.
Price reaction · baseline $2.04 (2024-04-19 close) · clean, no other EBS news in the window
day 0 close
+5.9%
day 1 · peak
+12.3%
day 3
-4.4%

Market Sentiment Analysis

POSITIVE FACTORS

  • Emergent BioSolutions will provide key business updates and revenue guidance.
  • The conference call offers insights into the first quarter financial results.
  • The company's proactive communication through a webcast indicates transparency.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+70%
120-day peak, hindsight
Typical move
8%
average across 2 past catalysts
Lead asset
FLU-IGIV
Phase 2 · Influenza A H3N2

Full Press Release Details

GAITHERSBURG, Md., April 22, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, May 1, 2024, at 5:00 pm eastern time to discuss the financial results for the first quarter 2024, key business updates, revenue guidance for the second quarter of 2024, and financial outlook for full year 2024.
Conference Call Information
Participants can access the conference call live via webcast. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call.
A replay of the call can be accessed from the Investors page of Emergent’s website.
About Emergent BioSolutions
Executive Vice President, CFO

Frequently Asked Questions

When is Emergent BioSolutions' conference call scheduled?

The conference call is on May 1, 2024, at 5:00 pm Eastern Time.

What will be discussed during the conference call?

The call will cover Q1 2024 financial results, business updates, and revenue guidance.

How can I access the conference call?

Participants can join via a live webcast or by registering for telephone access.

Will there be a replay of the conference call?

Yes, a replay will be available on the Investors page of Emergent's website.

ShareAdd on Google
Tags: EBS Viatris Investor Conferences Healthcare financial results conference call business updates revenue guidance
Last updated: Apr 22, 2024

Biotech snapshot

Cash runway
$141M liquidity · $0M/mo burn
Low dilution risk
Lead asset
FLU-IGIVPhase 2
Influenza A H3N2 →

Catalyst track record

+70%
best trade around EBS's most recent catalyst

Peak hindsight return over a 120-day window, across 2 tracked FDA/PDUFA catalysts for EBS.

See every catalyst's timing & PoA →